Onderzoeker
Ruth Van Daele
- Disciplines:Ontdekking en evaluatie van biomarkers, Ontdekking en evaluatie van geneesmiddelen, Medicinale producten, Farmaceutica, Farmacognosie en fytochemie, Farmacologie, Farmacotherapie, Toxicologie en toxinologie, Andere farmaceutische wetenschappen
Affiliaties
- Klinische Farmacologie en Farmacotherapie (Afdeling)
Lid
Vanaf1 okt 2017 → 30 sep 2022
Projecten
1 - 2 of 2
- Ontwikkeling, validatie en implementatie van veilige en effectieve doseringsstrategieën voor azole antifungale geneesmiddelen (M-ADVISED)Vanaf1 okt 2021 → HedenFinanciering: FWO Strategische Onderzoeksbeurs
- Klinische validatie van antifungale doseer-strategieën in kritiek zieke patiëntenVanaf1 okt 2021 → 30 sep 2022Financiering: BOF - postdoctorale mandaten
Publicaties
11 - 20 van 24
- Concomitant use of isavuconazole and CYP3A4/5 inducers: Where pharmacogenetics meets pharmacokinetics(2021)
Auteurs: Ruth Van Daele, Yves Debaveye, Robin Vos, Erwin Dreesen, Omar Elkayal, Pieter Vermeersch, Katrien Lagrou
Pagina's: 1111 - 1116 - A Population Pharmacokinetic Modeling and Simulation Study of Posaconazole Oral Suspension in Immunocompromised Pediatric Patients: A Short Communication(2021)
Auteurs: Omar Elkayal, Anne Uyttebroeck, Pieter Annaert, Karel Allegaert, Anne Smits, Ruth Van Daele, Erwin Dreesen
Pagina's: 512 - 518 - A Large Retrospective Assessment of Voriconazole Exposure in Patients Treated with Extracorporeal Membrane Oxygenation(2021)
Auteurs: Ruth Van Daele, Yves Debaveye, Joost Wauters, Christophe Vandenbriele
- Fluconazole Underexposure in Critically Ill Patients: a Matter of Using the Right Targets?(2021)
Auteurs: Ruth Van Daele, Yves Debaveye, Katrien Lagrou, Isabel Spriet
- Posaconazole for prevention of invasive pulmonary aspergillosis in critically ill influenza patients (POSA-FLU): a randomised, open-label, proof-of-concept trial(2021)
Auteurs: Lore Vanderbeke, Yves Debaveye, Simon Feys, Greet Hermans, Katrien Lagrou, Johan Maertens, Karin Thevissen, Ruth Van Daele, Alexander Wilmer, Joost Wauters
Pagina's: 674 - 686 - Pharmacokinetic/Pharmacodynamic Target Attainment Based on Measured versus Predicted Unbound Ceftriaxone Concentrations in Critically Ill Patients with Pneumonia: An Observational Cohort Study(2021)
Auteurs: Matthias Gijsen, Erwin Dreesen, Ruth Van Daele, Pieter Annaert, Yves Debaveye, Joost Wauters
- Pharmacokinetics and target attainment of intravenous posaconazole in critically ill patients during extracorporeal membrane oxygenation(2021)
Auteurs: Ruth Van Daele, Erwin Dreesen, Matthias Gijsen, Yves Debaveye, Joost Wauters
Pagina's: 1234 - 1241 - Ultra-performance liquid chromatography for quantification of amphotericin B plasma concentrations after use of liposomal amphotericin B(2021)
Auteurs: Ruth Van Daele, Joost Wauters, Johan Maertens, Isabel Spriet
Pagina's: 961 - 966 - Development and External Validation of an Online Clinical Prediction Model for Augmented Renal Clearance in Adult Mixed Critically Ill Patients: The Augmented Renal Clearance Predictor(2020)
Auteurs: Matthias Gijsen, Chao-yuan Huang, Ruth Van Daele, Peter Declercq, Yves Debaveye, Geert Meyfroidt, Joost Wauters, Isabel Spriet
Pagina's: E1260 - E1268 - Outpatient parenteral antifungal therapy (OPAT) for invasive fungal infections with intermittent dosing of liposomal amphotericin B(2020)
Auteurs: Ruth Van Daele, Isabel Spriet
Pagina's: 874 - 880